Skip to content

Effects of Different Exercise Durations on Cardiac Function and Prognosis in Patients with HFpEF: A Prospective Observational Study

Effects of Different Exercise Durations on Cardiac Function and Prognosis in Patients with HFpEF: A Prospective Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126771
Enrollment
Unknown
Registered
2026-06-15
Start date
2026-06-20
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

Observational group:None

Sponsors

The First Affiliated Hospital of Air Force Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Typical symptoms and/or signs of heart failure (e.g., dyspnea, edema); 2. Left ventricular ejection fraction (LVEF) >= 50%; 3. First-time hospitalized patients with New York Heart Association (NYHA) functional class II or III; 4. And must meet the criteria for left ventricular diastolic dysfunction/elevated left ventricular filling pressure, including elevated plasma natriuretic peptides [sinus rhythm: B-type natriuretic peptide (BNP) > 35 ng/L and/or N-terminal pro-B-type natriuretic peptide (NT-proBNP) > 125 ng/L; atrial fibrillation: BNP >= 105 ng/L or NT-proBNP >= 365 ng/L], and abnormal findings on resting or stress echocardiography or cardiac catheterization [ratio of early diastolic mitral inflow velocity to early diastolic tissue Doppler annular velocity (E/e') > 14 measured by echocardiography during exercise. Invasive hemodynamic testing: resting pulmonary capillary wedge pressure (PCWP) >= 15 mmHg (1 mmHg = 0.133 kPa) or left ventricular end-diastolic pressure >= 16 mmHg, or stress PCWP >= 25 mmHg].

Exclusion criteria

Exclusion criteria: 1. Patients with severe valvular disease, cardiac arrhythmia, angina pectoris, or pulmonary disease (vital capacity and/or forced expiratory volume in 1 second less than 80% of the age-predicted value); 2. Patients with untreated coronary artery stenosis > 50%; 3. Previous myocardial infarction; 4. Anemia (hemoglobin 150 mmHg or diastolic blood pressure > 100 mmHg; 7. Changes in cardiovascular medication regimen within the past 4 weeks.

Design outcomes

Primary

MeasureTime frame
Cardiac diastolic function;

Secondary

MeasureTime frame
1 year all cause readmission rate cardiovascular mortality; cardiovascular mortality;Exercise capacity;Quality of life;

Countries

China

Contacts

Public ContactZhang Bing

The First Affiliated Hospital of Air Force Military Medical University

zyn1045151706@163.com+86 188 4576 7143

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026